MedTrace Logo

CRAIL - Controlled Reperfusion of the Acutely Ischemic Limb

NCT00567801 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2008-07-28

No results posted yet for this study

Summary

The purpose of this study is to prove the findings of a preliminary study which strongly suggest the hypothesis that the result of conventional embolectomy for acute, severe lower-limb ischemia can be improved by controlled reperfusion.

Conditions

  • Lower Extremity Ischemia

Interventions

PROCEDURE

conventional embolectomy/thrombectomy

PROCEDURE

embolectomy/thrombectomy with controlled reperfusion

Sponsors & Collaborators

  • Dr. Köhler Chemie (Alsbach-Hähnlein, Germany)

    collaborator UNKNOWN

  • HP-Medica (Augsburg, Germany)

    collaborator UNKNOWN

  • GEA (Frederiksberg, Denmark)

    collaborator UNKNOWN

  • Kardialagut (München, Germany)

    collaborator UNKNOWN

  • University Hospital Freiburg

    lead OTHER

Principal Investigators

  • Friedhelm Beyersdorf, Prof. Dr. · Department of Cardiovascular Surgery, University Medical Center Freiburg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2009-09-30
Completion
2010-09-30

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00567801 on ClinicalTrials.gov